Polomar Health Services, Inc. (PMHS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 600K 1.2M 1.8M Q3 '22: 4.5K Q4 '22: 30K Q3 '23: 21.5K Q4 '23: 17.3K Q1 '24: 13.6K Q2 '24: 14.5K Q3 '24: 9.8K Q4 '24: 20.9K Q1 '25: 4.5K Q2 '25: 5.5K Q3 '25: 6.2K Q4 '25: 632.1K Q1 '26: 1M Q2 '26: 1.5M Q4 '22 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Gross Profit Quarterly

0 350K 700K 1.1M Q3 '22: 4.5K Q4 '22: 30K Q3 '23: 19.9K Q4 '23: 15.1K Q1 '24: 2.7K Q2 '24: 10.3K Q3 '24: 8.9K Q4 '24: 9.1K Q1 '25: 3.2K Q2 '25: 3.8K Q3 '25: 4.3K Q4 '25: 448.8K Q1 '26: 550.5K Q2 '26: 935.9K Q4 '22 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating Income Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q1 '22: -2.2K Q2 '22: -13.7K Q3 '22: -13.5K Q4 '22: -152K Q1 '23: -89.8K Q2 '23: -91K Q3 '23: -134.7K Q4 '23: -94.5K Q1 '24: -160.5K Q2 '24: -190.7K Q3 '24: -259.2K Q4 '24: -689.1K Q1 '25: -415.4K Q2 '25: -563.3K Q3 '25: -628.8K Q4 '25: -8.9M Q1 '26: -6.9K Q2 '26: 218.4K Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q1 '22: -2.2K Q2 '22: -13.7K Q3 '22: -13.4K Q4 '22: -151.7K Q1 '23: -89.8K Q2 '23: -91K Q3 '23: -172.2K Q4 '23: -127.6K Q1 '24: -160.5K Q2 '24: -190.7K Q3 '24: -271.3K Q4 '24: -718.8K Q1 '25: -456.9K Q2 '25: -605.6K Q3 '25: -649.8K Q4 '25: -9M Q1 '26: -25.4K Q2 '26: 200.4K Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 250K 500K 750K Q3 '23: 1.5K Q4 '23: 2.2K Q1 '24: 10.9K Q2 '24: 4.2K Q3 '24: 985 Q4 '24: 11.8K Q1 '25: 1.4K Q2 '25: 1.6K Q3 '25: 1.8K Q4 '25: 183.3K Q1 '26: 455K Q2 '26: 592.8K Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating Cash Flow Quarterly

-450K -300K -150K 0 150K 300K 450K Q3 '22: -13.1K Q4 '22: -15.6K Q1 '23: -73K Q2 '23: -91.4K Q3 '23: -149.7K Q4 '23: -220.1K Q1 '24: -164.8K Q2 '24: -247.9K Q3 '24: -292.1K Q4 '24: -315K Q1 '25: -45.6K Q2 '25: -187.8K Q3 '25: -352.7K Q4 '25: 190K Q1 '26: 34.4K Q2 '26: 121.3K Q4 '22 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Free Cash Flow Quarterly

-450K -300K -150K 0 150K 300K 450K Q1 '24: -206.2K Q2 '24: -286.7K Q3 '24: -302.8K Q4 '24: -315K Q1 '24 Q2 '24 Q3 '24 Q4 '24

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 40M 80M 120M Q2 '22: 313.6K Q3 '22: 266.2K Q1 '23: 108.5M Q2 '23: 108.6M Q3 '23: 27.7M Q1 '24: 27.7M Q2 '24: 27.7M Q3 '24: 27.7M Q1 '25: 27.7M Q2 '25: 27.7M Q3 '25: 28M Q1 '26: 28M Q2 '26: 28.1M Q2 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.45 -0.30 -0.15 0.00 0.15 0.30 0.45 Q4 '23: -0.02 Q1 '24: -0.03 Q2 '24: -0.04 Q3 '24: -0.04 Q4 '24: -0.06 Q1 '25: -0.07 Q2 '25: -0.08 Q3 '25: -0.09 Q4 '25: -0.39 Q1 '26: -0.37 Q2 '26: -0.35 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.